0001493152-22-012423.txt : 20220509 0001493152-22-012423.hdr.sgml : 20220509 20220509060516 ACCESSION NUMBER: 0001493152-22-012423 CONFORMED SUBMISSION TYPE: S-8 POS PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20220509 DATE AS OF CHANGE: 20220509 EFFECTIVENESS DATE: 20220509 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Kyto Technology & Life Science, Inc. CENTRAL INDEX KEY: 0001164888 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 651086538 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: S-8 POS SEC ACT: 1933 Act SEC FILE NUMBER: 333-120582 FILM NUMBER: 22903108 BUSINESS ADDRESS: STREET 1: 13050 PALOMA ROAD CITY: LOS ALTOS HILLS STATE: CA ZIP: 94022 BUSINESS PHONE: 650-204-7896 MAIL ADDRESS: STREET 1: 13050 PALOMA ROAD CITY: LOS ALTOS HILLS STATE: CA ZIP: 94022 FORMER COMPANY: FORMER CONFORMED NAME: KYTO BIOPHARMA INC DATE OF NAME CHANGE: 20030912 FORMER COMPANY: FORMER CONFORMED NAME: B TWELVE INC DATE OF NAME CHANGE: 20020111 S-8 POS 1 forms-8_pos.htm

 

As filed with the Securities and Exchange Commission on May 9, 2022

Registration No. 333-120582

 

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

POST-EFFECTIVE AMENDMENT NO. 1
TO

 

FORM S-8

 

REGISTRATION STATEMENTS
UNDER THE SECURITIES ACT OF 1933

 

 

 

KYTO TECHNOLOGY AND LIFE SCIENCE, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   65-1086538
 (State or other jurisdiction of
incorporation or organization)		    (I.R.S. Employer
Identification No.)

 

13050 Paloma Road, Los Altos Hills, CA 94022
(Address of principal executive offices)(Zip code)

 

Services Agreement

With Gerard Serfati

(Full title of the plan)

 

Paul Russo

Chief Executive Officer

Kyto Technology and Life Science, Inc.

13050 La Paloma Road

(Name and address of agent for service)

 

(650) 204-7896
(Telephone number, including area code, of agent for service)

 

 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer ☐   Accelerated filer ☐   Non-accelerated filer ☐
(Do not check if a smaller reporting company)		   Smaller reporting company ☒

 

 

 

 
 

 

TERMINATION OF REGISTRATION

 

This Post-Effective Amendment No. 1 (this “Amendment”) amends the Registration Statement on Form S-8 filed with the Securities and Exchange Commission (“SEC”) (Registration No. 333-120582) on November 18, 2004 (the “Registration Statement”), registering 4,500,000 shares of common stock of Kyto Technology and Life Science, Inc. (the “Company”) in connection with a services agreement between the Company and Gerard Serfati. The offering contemplated by the Registration Statement has terminated. This Amendment is being filed by the Company, in accordance with the undertaking made by the Company in the Registration Statement, to remove from registration all shares of common stock of the Company registered pursuant to this Registration Statement that remain unissued as of the date hereof.

  

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to the Registration Statements to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of San Francisco , State of California, on May 9, 2022.

 

  KYTO TECHNOLOGY AND LIFE SCIENCE, INC.
   
  By: /s/ Paul Russo
    Paul Russo
    Chief Executive Officer

 

Pursuant to the requirements of the Securities Act of 1933, this Post-Effective Amendment No. 1 to the Registration Statements has been signed on May 9, 2022 by the following persons in the capacities indicated.

 

/s/ Paul M. Russo    
Paul M. Russo   Chief Executive Officer and Director (Principal Executive Officer)
     
/s/ Simon Westbrook    
Simon Westbrook   Chief Financial Officer (Principal Financial Officer)
     
/s/ Mike Baghramian    
Mike Baghramian   Director
     
/s/ Jon S. Saxe    
Jon S. Saxe   Director
     
/s/ Peter D. Staple    
Peter D. Staple   Director